Both parties will leverage Fosun Pharma's capabilities in R&D, manufacturing, regulatory affairs and commercialization to accelerate the global launch of AR1001.
The collaboration integrates IQVIA’s AI‑enabled clinical trial capabilities to enhance speed, efficiency and confidence in decision-making throughout development.
Upperton is a UK-based CDMO providing integrated contract development and manufacturing services. Specializing in oral, nasal, pulmonary and sterile dosage forms, Upperton offers a comprehensive range of services designed to support the progression of a molecule from early feasibility through to formulation development, clinical trial manufacture and commercial manufacture.
As a premier, independently owned CDMO with over 65+ years of sterile injectable manufacturing experience, Simtra BioPharma Solutions (Simtra) offers world-class cGMP sterile fill/finish, technical expertise, quality service, and a uniquely collaborative approach. Pharmaceutical and biotech companies partner with Simtra when they face formulation challenges, clinical supply hurdles, surges in demand due to market fluctuations, or risk mitigation concerns. Our teams are driven to offer clients tailored and versatile solutions to help them bring their products to market.
